Antibacterial Action of Protein Fraction Isolated from <i>Rapana venosa</i> Hemolymph against <i>Escherichia coli</i> NBIMCC 8785

Natural products and especially those from marine organisms are being intensively explored as an alternative to synthetic antibiotics. However, the exact mechanisms of their action are not yet well understood. The molecular masses of components in the hemolymph fraction with MW 50–100 kDa from <i...

Full description

Bibliographic Details
Main Authors: Mihaela Kirilova, Yana Topalova, Lyudmila Velkova, Aleksandar Dolashki, Dimitar Kaynarov, Elmira Daskalova, Nellie Zheleva
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:Pharmaceuticals
Subjects:
Online Access:https://www.mdpi.com/1424-8247/17/1/68
_version_ 1797342820077404160
author Mihaela Kirilova
Yana Topalova
Lyudmila Velkova
Aleksandar Dolashki
Dimitar Kaynarov
Elmira Daskalova
Nellie Zheleva
author_facet Mihaela Kirilova
Yana Topalova
Lyudmila Velkova
Aleksandar Dolashki
Dimitar Kaynarov
Elmira Daskalova
Nellie Zheleva
author_sort Mihaela Kirilova
collection DOAJ
description Natural products and especially those from marine organisms are being intensively explored as an alternative to synthetic antibiotics. However, the exact mechanisms of their action are not yet well understood. The molecular masses of components in the hemolymph fraction with MW 50–100 kDa from <i>Rapana venosa</i> were determined using ImageQuant™ TL v8.2.0 software based on electrophoretic analysis. Mainly, three types of compounds with antibacterial potential were identified, namely proteins with MW at 50.230 kDa, 62.100 kDa and 93.088 kDa that were homologous to peroxidase-like protein, aplicyanin A and L-amino acid oxidase and functional units with MW 50 kDa from <i>R. venous</i> hemocyanin. Data for their antibacterial effect on <i>Escherichia coli</i> NBIMCC 8785 were obtained by CTC/DAPI-based fluorescent analysis (analysis based on the use of a functional fluorescence probe). The fluorescent analyses demonstrated that a 50% concentration of the fraction with MW 50–100 kDa was able to eliminate 99% of the live bacteria. The antimicrobial effect was detectable even at a 1% concentration of the active compounds. The bacteria in this case had reduced metabolic activity and a 24% decreased size. The fraction had superior action compared with another mollusc product—snail slime—which killed 60% of the <i>E. coli</i> NBIMCC 8785 cells at a 50% concentration and had no effect at a 1% concentration. The obtained results demonstrate the high potential of the fraction with MW 50–100 kDa from <i>R. venosa</i> to eliminate and suppress the development of <i>Escherichia coli</i> NBIMCC 8785 bacteria and could be applied as an appropriate component of therapeutics with the potential to replace antibiotics to avoid the development of antibiotic resistance.
first_indexed 2024-03-08T10:38:43Z
format Article
id doaj.art-af6427a46d834a88a438832fe4763b4e
institution Directory Open Access Journal
issn 1424-8247
language English
last_indexed 2024-03-08T10:38:43Z
publishDate 2024-01-01
publisher MDPI AG
record_format Article
series Pharmaceuticals
spelling doaj.art-af6427a46d834a88a438832fe4763b4e2024-01-26T18:05:39ZengMDPI AGPharmaceuticals1424-82472024-01-011716810.3390/ph17010068Antibacterial Action of Protein Fraction Isolated from <i>Rapana venosa</i> Hemolymph against <i>Escherichia coli</i> NBIMCC 8785Mihaela Kirilova0Yana Topalova1Lyudmila Velkova2Aleksandar Dolashki3Dimitar Kaynarov4Elmira Daskalova5Nellie Zheleva6Faculty of Biology, Sofia University, 8 Dragan Tzankov blvd., 1164 Sofia, BulgariaFaculty of Biology, Sofia University, 8 Dragan Tzankov blvd., 1164 Sofia, BulgariaInstitute of Organic Chemistry with Centre of Phytochemistry, Bulgarian Academy of Sciences, Acad. Georgi Bonchev str., bl. 9, 1113 Sofia, BulgariaInstitute of Organic Chemistry with Centre of Phytochemistry, Bulgarian Academy of Sciences, Acad. Georgi Bonchev str., bl. 9, 1113 Sofia, BulgariaInstitute of Organic Chemistry with Centre of Phytochemistry, Bulgarian Academy of Sciences, Acad. Georgi Bonchev str., bl. 9, 1113 Sofia, BulgariaFaculty of Biology, Sofia University, 8 Dragan Tzankov blvd., 1164 Sofia, BulgariaCenter of Competence “Clean Technologies for Sustainable Environment—Water, Waste, Energy for Circular Economy”, 1000 Sofia, BulgariaNatural products and especially those from marine organisms are being intensively explored as an alternative to synthetic antibiotics. However, the exact mechanisms of their action are not yet well understood. The molecular masses of components in the hemolymph fraction with MW 50–100 kDa from <i>Rapana venosa</i> were determined using ImageQuant™ TL v8.2.0 software based on electrophoretic analysis. Mainly, three types of compounds with antibacterial potential were identified, namely proteins with MW at 50.230 kDa, 62.100 kDa and 93.088 kDa that were homologous to peroxidase-like protein, aplicyanin A and L-amino acid oxidase and functional units with MW 50 kDa from <i>R. venous</i> hemocyanin. Data for their antibacterial effect on <i>Escherichia coli</i> NBIMCC 8785 were obtained by CTC/DAPI-based fluorescent analysis (analysis based on the use of a functional fluorescence probe). The fluorescent analyses demonstrated that a 50% concentration of the fraction with MW 50–100 kDa was able to eliminate 99% of the live bacteria. The antimicrobial effect was detectable even at a 1% concentration of the active compounds. The bacteria in this case had reduced metabolic activity and a 24% decreased size. The fraction had superior action compared with another mollusc product—snail slime—which killed 60% of the <i>E. coli</i> NBIMCC 8785 cells at a 50% concentration and had no effect at a 1% concentration. The obtained results demonstrate the high potential of the fraction with MW 50–100 kDa from <i>R. venosa</i> to eliminate and suppress the development of <i>Escherichia coli</i> NBIMCC 8785 bacteria and could be applied as an appropriate component of therapeutics with the potential to replace antibiotics to avoid the development of antibiotic resistance.https://www.mdpi.com/1424-8247/17/1/68<i>Rapana venosa</i> hemolymph<i>Escherichia coli</i> NBIMCC 8785antimicrobial effect
spellingShingle Mihaela Kirilova
Yana Topalova
Lyudmila Velkova
Aleksandar Dolashki
Dimitar Kaynarov
Elmira Daskalova
Nellie Zheleva
Antibacterial Action of Protein Fraction Isolated from <i>Rapana venosa</i> Hemolymph against <i>Escherichia coli</i> NBIMCC 8785
Pharmaceuticals
<i>Rapana venosa</i> hemolymph
<i>Escherichia coli</i> NBIMCC 8785
antimicrobial effect
title Antibacterial Action of Protein Fraction Isolated from <i>Rapana venosa</i> Hemolymph against <i>Escherichia coli</i> NBIMCC 8785
title_full Antibacterial Action of Protein Fraction Isolated from <i>Rapana venosa</i> Hemolymph against <i>Escherichia coli</i> NBIMCC 8785
title_fullStr Antibacterial Action of Protein Fraction Isolated from <i>Rapana venosa</i> Hemolymph against <i>Escherichia coli</i> NBIMCC 8785
title_full_unstemmed Antibacterial Action of Protein Fraction Isolated from <i>Rapana venosa</i> Hemolymph against <i>Escherichia coli</i> NBIMCC 8785
title_short Antibacterial Action of Protein Fraction Isolated from <i>Rapana venosa</i> Hemolymph against <i>Escherichia coli</i> NBIMCC 8785
title_sort antibacterial action of protein fraction isolated from i rapana venosa i hemolymph against i escherichia coli i nbimcc 8785
topic <i>Rapana venosa</i> hemolymph
<i>Escherichia coli</i> NBIMCC 8785
antimicrobial effect
url https://www.mdpi.com/1424-8247/17/1/68
work_keys_str_mv AT mihaelakirilova antibacterialactionofproteinfractionisolatedfromirapanavenosaihemolymphagainstiescherichiacoliinbimcc8785
AT yanatopalova antibacterialactionofproteinfractionisolatedfromirapanavenosaihemolymphagainstiescherichiacoliinbimcc8785
AT lyudmilavelkova antibacterialactionofproteinfractionisolatedfromirapanavenosaihemolymphagainstiescherichiacoliinbimcc8785
AT aleksandardolashki antibacterialactionofproteinfractionisolatedfromirapanavenosaihemolymphagainstiescherichiacoliinbimcc8785
AT dimitarkaynarov antibacterialactionofproteinfractionisolatedfromirapanavenosaihemolymphagainstiescherichiacoliinbimcc8785
AT elmiradaskalova antibacterialactionofproteinfractionisolatedfromirapanavenosaihemolymphagainstiescherichiacoliinbimcc8785
AT nelliezheleva antibacterialactionofproteinfractionisolatedfromirapanavenosaihemolymphagainstiescherichiacoliinbimcc8785